{"type":"root","children":[{"type":"paragraph","children":[{"type":"text","value":"Somatostatin Receptor 2 (SSTR2) is one of five subtypes of the somatostatin receptors, which belong to the G protein-coupled receptors (GPCRs) superfamily. SSTR2 is encoded by the SSTR2 gene, located on chromosome 17q25.1. SSTR2 is widely distributed in various tissues, including the central nervous system, endocrine glands, and gastrointestinal tract. Activation of SSTR2 by somatostatin inhibits the release of several hormones, including growth hormone, insulin, glucagon, gastrin, and serotonin. SSTR2-mediated inhibition of hormone secretion contributes to the regulation of physiological processes such as growth, metabolism, and digestion. SSTR2 expression is commonly observed in neuroendocrine tumors, which arise from neuroendocrine cells dispersed throughout the body. Immunohistochemical staining for SSTR2 expression is used in pathology to identify and characterize neuroendocrine tumors, including gastroenteropancreatic neuroendocrine tumors (GEP-NETs), bronchopulmonary neuroendocrine tumors (BP-NETs), and neuroendocrine carcinomas (NECs). SSTR2 expression may also be detected in non-neuroendocrine tissues and cells, including certain immune cells, neuronal cells, and tumors of non-neuroendocrine origin. The functional significance of SSTR2 expression in these contexts is less well understood and may vary depending on the specific cellular context and signaling pathways involved."}]}]}